CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000DJ33DQ1

Market Closed - Deutsche Boerse AG 15:34:15 2024-05-24 EDT
51.06 EUR +2.14% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+5.63%
1 month+7.04%
Date Price Change
24-05-24 51.06 +2.14%
24-05-23 49.99 -1.79%
24-05-22 50.9 -1.85%
24-05-21 51.86 -1.26%
24-05-20 52.52 +0.32%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 03:34 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ33DQ
ISINDE000DJ33DQ1
Date issued 2023-07-13
Strike 60
Maturity 2024-12-20 (209 Days)
Parity 1 : 1
Emission price 50.88
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 53.28
Lowest since issue 31.72
Spread 0.1
Spread %0.20%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.16%
Consensus